MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	31.70M -28.2%
Revenue (ttm)	9.51M +114.7%
Net Income	-5.57M
EPS	-0.09
Shares Out	70.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,978
Open	0.4400
Previous Close	0.4500
Day's Range	0.4000 - 0.4400
52-Week Range	0.2900 - 0.9400
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2025, MustGrow Biologics's revenue was 8.29 million, an increase of 1981.95% compared to the previous year's 398,018. Losses were -7.26 million, 48.5% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error